Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutics Targets for Tyrosine Kinase Inhibitors

被引：0
|
作者：
Brandi, Giovanni [1 ,2 ]
Tavolari, Simona [3 ,4 ]
Biasco, Guido [1 ,2 ]
机构：
[1] Univ Bologna, St Orsola Malpighi Hosp, Lorenzo & Ariosto Seragnoli Dept Hematol & Oncol, Bologna, Italy
[2] Univ Bologna, G Prodi Interdept Ctr Canc Res CIRC, Bologna, Italy
[3] Univ Bologna, Lorenzo & Ariosto Seragnoli Dept Hematol & Oncol, Bologna, Italy
[4] Univ Bologna, St Orsola Malpighi Hosp, Ctr Appl Biomed Res CRBA, Bologna, Italy
来源：
GASTROENTEROLOGY | 2012年 / 143卷 / 04期
关键词：
INTRAHEPATIC CHOLANGIOCARCINOMA;
D O I：
10.1053/j.gastro.2012.07.120
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E20 / E21
页数：2
相关论文
共 50 条
  • [1] Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutics Targets for Tyrosine Kinase Inhibitors Reply
    Andersen, Jesper B.
    Thorgeirsson, Snorri S.
    [J]. GASTROENTEROLOGY, 2012, 143 (04) : E21 - E21
  • [2] Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
    Andersen, Jesper B.
    Spee, Bart
    Blechacz, Boris R.
    Avital, Itzhak
    Komuta, Mina
    Barbour, Andrew
    Conner, Elizabeth A.
    Gillen, Matthew C.
    Roskams, Tania
    Roberts, Lewis R.
    Factor, Valentina M.
    Thorgeirsson, Snorri S.
    [J]. GASTROENTEROLOGY, 2012, 142 (04) : 1021 - U552
  • [3] GENOMIC AND GENETIC CHARACTERIZATION OF HUMAN CHOLANGIOCARCINOMA IDENTIFIES TREATMENT OPTIONS FOR TYROSINE KINASE INHIBITORS
    Andersen, Jesper B.
    Spee, Bart
    Blechacz, Boris
    Avital, Itzhak
    Komuta, Mina
    Barbour, Andrew
    Roskams, Tania
    Roberts, Lewis R.
    Factor, Valentina M.
    Thorgeirsson, Snorri S.
    [J]. HEPATOLOGY, 2011, 54 : 777A - 778A
  • [4] Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics
    Tibes, R
    Trent, J
    Kurzrock, R
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 : 357 - +
  • [5] Role of protein tyrosine kinase inhibitors in cancer therapeutics
    Bhise, SB
    Nalawade, AD
    Wadhawa, H
    [J]. INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2004, 41 (06): : 273 - 280
  • [6] New targets identified for tyrosine kinase inhibitors
    Rousselot, Philippe
    [J]. HEMATOLOGIE, 2007, 13 (05): : 283 - 284
  • [7] Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
    Elena V. Poddubskaya
    Madina P. Baranova
    Daria O. Allina
    Philipp Y. Smirnov
    Eugene A. Albert
    Alexey P. Kirilchev
    Alexey A. Aleshin
    Marina I. Sekacheva
    Maria V. Suntsova
    [J]. Experimental Hematology & Oncology, 7
  • [8] Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
    Poddubskaya, Elena V.
    Baranova, Madina P.
    Allina, Daria O.
    Smirnov, Philipp Y.
    Albert, Eugene A.
    Kirilchev, Alexey P.
    Aleshin, Alexey A.
    Sekacheva, Marina I.
    Suntsova, Maria V.
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2018, 7
  • [9] Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma
    McKay, Siobhan C.
    Unger, Kristian
    Pericleous, Stephanos
    Stamp, Gordon
    Thomas, Gerry
    Hutchins, Robert R.
    Spalding, Duncan R. C.
    [J]. HPB, 2011, 13 (05) : 309 - 319
  • [10] Molecular targets of tyrosine kinase inhibitors in thyroid cancer
    Fallahi, Poupak
    Ferrari, Silvia Martina
    Galdiero, Maria Rosaria
    Varricchi, Gilda
    Elia, Giusy
    Ragusa, Francesca
    Paparo, Sabrina Rosaria
    Benvenga, Salvatore
    Antonelli, Alessandro
    [J]. SEMINARS IN CANCER BIOLOGY, 2022, 79 : 180 - 196
12345